ONCODESIGN
Pharmacological expertise for anticancer therapies from target to patient : a unique oncology preclinical CRO. Founded in 1995, Oncodesign is a biopharmaceutical company that fills in the innovation gaps in the healthcare industry, based on its unique precision medicine platform. Technological innovation lies at the heart of Oncodesignโs modelโthe Etiology, Discovery and Experimentation activities designed and implemented by Oncodesign contribute to a more effective approach to the phenome... non of innate and acquired resistance, more effective treatments and a reduction in therapeutic failures. Working alongside big pharma, biotechโs, public research institutions and investment groups, Oncodesign orients the research and development of new therapeutic and diagnostic tools. Through its range of services, partnerships and licensing programs, Oncodesignโs offering can meet the full range of innovation needs. Oncodesign is listed on the Euronext Growth Paris market and possesses a stable ownership structure with a majority owner committed to its development.
ONCODESIGN
Industry:
Biotechnology Health Care Therapeutics
Founded:
1995-01-01
Address:
Dijon, Bourgogne, France
Country:
France
Website Url:
http://www.oncodesign.com
Total Employee:
101+
Status:
Active
Contact:
+33 (0)3.80.78.82.60
Email Addresses:
[email protected]
Total Funding:
29.41 M USD
Technology used in webpage:
Mobile Non Scaleable Content ASP.NET 3 To 9 CcTLD Redirects Orange
Similar Organizations
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
OncoGenex
OncoGenex develops and commercializes innovative therapies for the treatment of a variety of cancers.
OncoTherapy Science
OncoTherapy Science deliver cancer therapeutics and treatments to patients suffering from cancer.
Progenteq
Progenteq develops cartilage repair therapy to regenerate damaged cartilage.
WntResearch
WntResearch develops anti-metastatic therapies for the treatment of cancer patients.
Current Employees Featured
Founder
Stock Details
Investors List
Osรฉo
Osรฉo investment in Venture Round - Oncodesign
Banque de Vizille
Banque de Vizille investment in Series C - Oncodesign
Avenir Entreprises Gestion
Avenir Entreprises Gestion investment in Series C - Oncodesign
Official Site Inspections
http://www.oncodesign.com Semrush global rank: 4.45 M Semrush visits lastest month: 2.46 K
- Host name: od-5e32b6.ch2.infomaniak.ch
- IP address: 195.15.224.139
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich